Next-generation Sequencing Market by Product (Reagents, Kits, Platforms), Service (CHIP Sequencing, Whole Genome, Methyl, RNA Sequencing), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Application, Competition - Global Forecast to 2031

Market Size
$13.81B
MARKET SIZE, 2026
Projected Market Size
$27.14B
MARKET SIZE, 2031
CAGR
14.5%
CAGR (2026-2031)
Forecast Period
2026-2031
FORECAST PERIOD

NEXT-GENERATION SEQUENCING MARKET SIZE, SHARE & GROWTH SNAPSHOT

next-generation-sequencing-ngs-technologies-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global next-generation sequencing market is projected to grow from USD 13.81 billion in 2026 to USD 27.14 billion by 2031, at a CAGR of 14.5% during the forecast period. The market was valued at USD 12.77 billion in 2025. The expansion of the next-generation sequencing market is largely attributed to rapid improvements in sequencing technologies, rising demand for precision medicine, declining sequencing costs, and the increasing range of clinical applications.

KEY TAKEAWAYS

  • MARKET SNAPSHOT:
    Base Year Market Size (2025): USD 12.77 Billion
    Current Market Size (2026): USD 13.81 Billion
    Forecast Market Size (2031): USD 27.14 Billion
    CAGR (2026–2031): 14.5%
  • SEGMENT LEADERSHIP:
    Regional Leader: North America accounted for 42.5% of the global next-generation sequencing market in 2025.
    Fastest-Growing Offering: Services are projected to register the highest CAGR of 18.8% during the forecast period.
    Fastest-Growing Application: Diagnostics is projected to grow at the highest CAGR of 14.9% during 2026–2031.
    Product End User Leader: Clinical & diagnostics laboratories dominated the product market in 2025.
    Service End User Leader: Academic & research institutes dominated the services market in 2025.
  • MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
    Leading companies include PacBio, Illumina, Inc., Thermo Fisher Scientific, and Agilent Technologies.
    Emerging companies such as Singular Genomics Systems and Nucleus Biotech GmbH have established strong positions in specialized market segments.

The next-generation sequencing (NGS) market continues to grow steadily. A key driver of this expansion is the clinical adoption of NGS across oncology, rare diseases, reproductive health, and infectious diseases. This trend is also accompanied by lower cost per genome and the launch of higher-throughput benchtop and clinical instruments. In addition, growth is further fueled by kitted library prep workflows, automation, and cloud/AI analytics that shorten sample-to-report times and improve data quality. Moreover, the emergence of national genomics initiatives, CDx/liquid biopsy (MRD) programs, long-read and single-cell/spatial multiomics, and collaborations among health systems, CROs, and platform providers are reshaping the competitive landscape. These changes are also deepening the recurring consumables and services base.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The next-generation sequencing landscape is changing. As the market shifts toward large-scale clinical use, there is a growing need for automated workflows and shorter turnaround times. The shifts in modality (long-read, single-cell/spatial, real-time nanopore) are broadening applications and, therefore, supporting growth in informatics, storage, and cloud/AI analytics. Stringent in vitro diagnostic regulations and more demanding payer evidence requirements are, therefore, setting higher standards for validation, LIMS traceability, and clinical utility demonstration.

next-generation-sequencing-ngs-technologies-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Advancements in sequencing platforms
  • Rising clinical applications of sequencing
RESTRAINTS
Impact
Level
  • High capital investments and expenses
  • Data analysis complexity
OPPORTUNITIES
Impact
Level
  • Adoption of long-read sequencing technologies
  • Integration of AI and ML
CHALLENGES
Impact
Level
  • Standardization Issues

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Advancements in sequencing platforms

Sequencing platforms have become faster, more accurate, and more user-friendly through various technological advances. With the ability to process large genomes and diverse samples in a single run, researchers can achieve quicker turnaround times, resulting in both cost and effort savings. Enhanced sequencing chemistries, such as more efficient fluorescent labeling and increased error correction, have contributed to higher data quality. NGS technology is now within reach of smaller laboratories and clinics, facilitated by the availability of compact automated systems and benchtop sequencers.

Restraint: High capital investments and expenses

High initial capital investment is a significant restraint on the NGS market, limiting adoption, especially in smaller labs, academic institutions, and emerging markets. The purchase price of advanced sequencing instruments ranges from hundreds of thousands to millions of dollars, creating a heavy financial burden. For instance, setting up an NGS facility requires investments in data storage, high-performance computing systems, and lab automation tools. Cost implications also include ongoing personnel training, equipment maintenance, and the continuous procurement of consumables.

Opportunity: Adoption of long-read sequencing technologies

The adoption of long-read sequencing technologies presents significant opportunities in the next-generation sequencing market by addressing critical challenges of short-read methods. Long-read platforms, such as those offered by Pacific Biosciences and Oxford Nanopore Technologies, enable sequencing of longer DNA or RNA fragments, producing more comprehensive and accurate genome assemblies. This is especially useful for analyzing complex genomic regions, such as structural variations, repetitive sequences, and phased haplotypes, which are difficult to resolve with short-read technologies.

Challenge: Standardization Issues

Standardization issues pose a significant challenge in the next-generation sequencing market, undermining the reproducibility, reliability, and scalability of sequencing workflows. The absence of uniform protocols for sample preparation, library construction, and data analysis leads to variability in results across laboratories and platforms. This inconsistency can hinder dataset comparability and complicate multi-center studies or collaborative research projects. In clinical applications, the lack of standardized guidelines for test validation and regulatory compliance, particularly across regions, creates hurdles to the widespread adoption of NGS-based diagnostics.

NEXT GENERATION SEQUENCING MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Nationwide clinical whole genome sequencing (WGS) for rare disease & cancer using Illumina NovaSeq/HiSeq + DRAGEN pipelines. Higher diagnostic yield | Shorter diagnostic odyssey | Scalable national service.
Targeted oncology/constitutional testing on Thermo Fisher Ion Torrent (Oncomine/AmpliSeq) panels within a CLIA lab. Rapid panel TAT | Cost-effective targeted profiling with established QC.
Clinical WGS service on Illumina platforms integrated with lab LIMS and confirmatory orthogonal tests. Broader diagnostic yield | Standardized clinical reporting.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The ecosystem perspective of the next-generation sequencing market reveals the interconnected stakeholders, resources, and interactions that support the industry. The core consists of organizations directly involved in the development, manufacturing, distribution, and use of sequencing technologies. These include technology innovators, consumables suppliers, service providers, and end users such as research institutes, clinical laboratories, and biotechnology companies. Moreover, regulators and standards bodies, which influence market direction, innovation priorities, and the responsible use of genomic data, are also key players.

next-generation-sequencing-ngs-technologies-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

next-generation-sequencing-ngs-technologies-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Next-Generation Sequencing (NGS) Market, By Offering

In 2025, the products segment held the largest share of the market, driven by repeat purchases and steady workflow demand. Most sequencing labs consistently spend on library prep kits, sequencing reagents, flow cells/chips, sample prep consumables, and QC reagents, making products a critical part of NGS operations.

Next-Generation Sequencing Products Market, By Type

In 2025, consumables dominated the NGS products market because they are used in every run and repurchased continuously. This includes library preparation kits, sequencing reagents, flow cells/chips, target enrichment panels, buffers, and other consumables. Moreover, sequencing volumes are increasing in clinical testing (mainly for oncology, NIPT, rare disease, and infectious disease) and in large research programs (population genomics, longitudinal studies), driving higher reagent consumption.

Next-Generation Sequencing Platforms Market, By Technology

Sequencing by synthesis (SBS) was the dominant technology in the NGS platforms market in 2025, largely due to its excellent combination of high accuracy, high throughput, and low cost. SBS instruments are widely used in large-scale genomics centers as well as in routine laboratories; thus, they have become a preferred choice for whole-genome, whole-exome, targeted panels, transcriptomics, and other high-volume applications.

Next-Generation Sequencing Products Market, By Workflow

In 2025, the sequencing step dominated the NGS products market by workflow because it drives the highest recurring spend per sample. Once libraries are prepared, every run requires sequencing kits and reagents, flow cells or sequencing chips, buffers, and run-specific plastics. These costs scale directly with sample volume and depth of coverage.

Next-Generation Sequencing Services Market, By Type

Sequencing services led the NGS services market by type in 2025, largely because the majority of customers outsource the most resource-intensive step. Sequencing requires costly equipment, qualified personnel, stringent quality control, and a continuous supply of reagents, all of which are difficult for small laboratories to sustain internally. Moreover, service providers are a favored choice for projects with fluctuating sample volumes, as they offer short turnaround times, uniform workflows, and scalable capacity.

Next-Generation Sequencing (NGS) Market, By Application

In 2025, diagnostics held the largest share of the NGS services market by application, as clinical demand shifted from research to routine patient testing. Oncology testing was a key focus. Many labs outsourced comprehensive genomic profiling and MRD-focused sequencing to access validated workflows and consistent reporting.

REGION

Asia Pacific to be fastest-growing region in global next-generation sequencing market during forecast period

The Asia Pacific next-generation sequencing market is expected to grow at the fastest rate during the forecast period. This region, with its diverse population and a range of genetic backgrounds and healthcare issues, would benefit from NGS. NGS enables the comprehension of genetic diversity, the identification of disease-causing mutations, and the creation of regionally specific healthcare solutions. Ongoing development will lead to genomic advancements and better healthcare delivery, and the Asia Pacific region is expected to witness a sharp increase in the use of these technologies in research and clinical settings.

next-generation-sequencing-ngs-technologies-market Region

NEXT GENERATION SEQUENCING MARKET: COMPANY EVALUATION MATRIX

In the NGS market matrix, Illumina (Star) leads with a large installed base of clinical and research sequencers (for example, high-throughput and benchtop platforms), an anchored consumables model, and integrated secondary analysis. This breadth across oncology, rare-disease, reproductive health, and surveillance applications, combined with global service and regulatory-ready workflows, positions Illumina as the reference vendor for many laboratories. BD (Emerging Leader) is strengthening its position through single-cell and sample-to-sequencing workflows, bridging cellular phenotyping with NGS readouts. As multi-omics and cell-resolved applications expand, BD's portfolio depth in cell preparation and single-cell library generation supports progression toward the leaders' quadrant.

next-generation-sequencing-ngs-technologies-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 12.77 Billion
Market Forecast in 2031 (Value) USD 27.14 Billion
Growth Rate CAGR of 14.5% from 2026-2031
Years Considered 2024-2031
Base Year 2025
Forecast Period 2026-2031
Units Considered Value (USD Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Offerings:
    • Products
    • Services
  • Products, By Type:
    • Consumables (Library Preparation Kits & Reagents
    • Sequencing Kits & Reagents
    • Other Consumables)
    • Platforms (Sequencing Platforms
    • Library Preparation Platforms)
    • Bioinformatics Tools (Data Analysis Software & Workbenches
    • Data Visualization Tools
    • Other Bioinformatics Tools)
  • Platforms, By Technology:
    • Sequencing By Synthesis
    • Ion Semiconductor Sequencing
    • Single-Molecule Real Time Sequencing
    • Nanopore Sequencing
    • Other Sequencing Technologies
  • Products, By Workflow:
    • Sequencing
    • Presequencing
    • Data Analysis
  • Products, By End User:
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Clinical & Diagnostics Laboratories
    • Other End Users
  • Services, By Type:
    • Sequencing Services (Exome & Targeted Resequencing and Custom Panels
    • RNA Sequencing
    • De Novo Sequencing
    • Chip Sequencing
    • Whole Genome Sequencing
    • Methyl Sequencing
    • Other Sequencing Services)
    • Presequencing Services (Library Preparation & Target Enrichment
    • Sample Preparation
    • Quality Control)
    • Bioinformatics & Data Analysis Services (Data Analysis
    • Data Visualization & Interpretation
    • Data Storage & Management Services)
    • NGS Platform Services
  • Services, By Workflow:
    • Sequencing Services
    • Presequencing Services
    • Data Analysis Services
  • Services, By End User:
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Hospitals & Clinical Laboratories
    • Other End Users)
  • By Application:
    • Diagnostics (Cancer Diagnostics
    • Infectious Disease Diagnostics
    • Reproductive Health Diagnostics
    • Other Diagnostic Applications)
    • Drug Discovery & Development (Pharmacogenomics
    • Other Drug Discovery & Development Applications)
    • Agriculture & Animal Research
    • Other Applications
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East, Africa
Related Segment & Geographic Reports Next-Generation Sequencing (NGS) Services Market
North America Next Generation Sequencing Market
Europe Next Generation Sequencing Market
Asia Pacific Next Generation Sequencing Market
Germany Next Generation Sequencing Market
France Next Generation Sequencing Market
UK Next-generation Sequencing Market
South Korea Next-Generation Sequencing Market
China Next Generation Sequencing Market
Single-Molecule Real Time (SMRT) Sequencing Market

WHAT IS IN IT FOR YOU: NEXT GENERATION SEQUENCING MARKET REPORT CONTENT GUIDE

next-generation-sequencing-ngs-technologies-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
US Next-Generation Sequencing (NGS) Market Assessment Country-level sizing and forecast by technology, application, and end user, including pricing and adoption trends Enables focused market strategy and investment planning in the US NGS space
Competitive Benchmarking of Leading Companies Comparative profiling of key NGS players covering platform offerings, technological advancements, pricing, and strategic partnerships Provides insights into competitor strengths and market positioning for strategic decision-making

RECENT DEVELOPMENTS

  • September 2025 : Illumina announced the launch of Illumina Protein Prep, an assay designed for next-generation sequencing (NGS)-based proteomics research. The product enables integration of proteomics into large-scale genomics studies across cancer, cardiometabolic, and immunologic research.
  • July 2025 : QIAGEN launched its new QIAseq xHYB Long Read Panels, a set of target enrichment tools designed to support long-read sequencing of complex genomic regions. The panels are optimized for compatibility with native long-read platforms, such as those from PacBio, and are intended to improve detection of a broader range of genomic variations.
  • February 2025 : Roche announced the launch of its sequencing by expansion (SBX) technology, a proprietary next-generation sequencing method. The SBX chemistry, paired with a sensor module, is designed to enable rapid, scalable sequencing for various applications.

 

Table of Contents

checkmarkExclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
58
2
EXECUTIVE SUMMARY
 
 
 
 
 
63
3
PREMIUM INSIGHTS
 
 
 
 
 
68
4
MARKET OVERVIEW
Unlock growth with AI-enhanced sequencing, precision medicine, and multiomics integration amid cost declines.
 
 
 
 
 
71
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
ADVANCEMENTS IN SEQUENCING PLATFORMS
 
 
 
 
 
 
4.2.1.2
RISING CLINICAL APPLICATIONS OF SEQUENCING
 
 
 
 
 
 
4.2.1.3
GROWING DEMAND FOR PRECISION MEDICINE
 
 
 
 
 
 
4.2.1.4
DECLINING COSTS OF SEQUENCING
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
DATA ANALYSIS COMPLEXITY
 
 
 
 
 
 
4.2.2.2
HIGH CAPITAL INVESTMENTS AND EXPENSES
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
INTEGRATION OF AI AND ML
 
 
 
 
 
 
4.2.3.2
ADOPTION OF LONG-READ SEQUENCING TECHNOLOGIES
 
 
 
 
 
 
4.2.3.3
EMPHASIS ON MULTIOMICS INTEGRATION
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
STANDARDIZATION ISSUES
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
 
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
4.5
STRATEGIC MOVIES BY TIER 1/2/3 PLAYERS
 
 
 
 
 
5
INDUSTRY TRENDS
Navigate competitive landscapes with insights on supplier dynamics and emerging global R&D trends.
 
 
 
 
 
78
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
 
5.1.2
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.4
THREAT FROM SUBSTITUTES
 
 
 
 
 
 
5.1.5
THREAT FROM NEW ENTRANTS
 
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
 
 
5.2.3
R&D TRENDS IN GLOBAL HEALTHCARE INDUSTRY
 
 
 
 
 
 
5.2.4
R&D TRENDS IN GLOBAL BIOTECH INDUSTRY
 
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
 
5.4.1
ROLE OF PLAYERS IN ECOSYSTEM
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER
 
 
 
 
 
 
 
5.5.1.1
AVERAGE SELLING PRICE TREND OF PLATFORMS, BY KEY PLAYER
 
 
 
 
 
 
5.5.1.2
AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER
 
 
 
 
 
5.5.2
AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER
 
 
 
 
 
 
5.5.3
AVERAGE SELLING PRICE TREND, BY REGION
 
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
IMPORT SCENARIO (HS CODE 382200)
 
 
 
 
 
 
5.6.2
EXPORT SCENARIO (HS CODE 382200)
 
 
 
 
 
 
5.6.3
IMPORT SCENARIO (HS CODE 902700)
 
 
 
 
 
 
5.6.4
EXPORT SCENARIO (HS CODE 902700)
 
 
 
 
 
5.7
KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
5.9
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
 
 
5.10
CASE STUDY ANALYSIS
 
 
 
 
 
 
 
5.10.1
COMPREHENSIVE GENOMIC PROFILING TEST EXPANDS PRECISION ONCOLOGY APPLICATIONS
 
 
 
 
 
 
5.10.2
ULTRA-SENSITIVE NGS PANEL ENABLES MEASURABLE RESIDUAL DISEASE MONITORING
 
 
 
 
 
 
5.10.3
NGS-BASED MYELOID FUSION PANEL ENHANCES HEMATOLOGIC MALIGNANCY RESEARCH
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFF ON NEXT-GENERATION SEQUENCING MARKET
 
 
 
 
 
 
 
 
5.11.1
INTRODUCTION
 
 
 
 
 
 
5.11.2
KEY TARIFF RATES
 
 
 
 
 
 
5.11.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.11.4
IMPACT ON COUNTRY/REGION
 
 
 
 
 
 
 
5.11.4.1
US
 
 
 
 
 
 
5.11.4.2
EUROPE
 
 
 
 
 
 
5.11.4.3
ASIA PACIFIC
 
 
 
 
 
5.11.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
 
 
5.11.5.1
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
5.11.5.2
CROS AND ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
5.11.5.3
HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS
 
 
 
6
CUSTOMER LANDSCAPE & BUYER BEHAVIOUR
Unlock the complexities of buyer dynamics and unmet needs in NGS product adoption.
 
 
 
 
 
107
 
6.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
6.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
6.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
6.2.2
KEY BUYING CRITERIA FOR NGS PRODUCTS, BY END USER
 
 
 
 
 
6.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
6.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
Navigate global sustainability with insights on regional regulations and compliance impacts.
 
 
 
 
 
111
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
 
 
 
7.1.2.1
NORTH AMERICA
 
 
 
 
 
 
7.1.2.2
EUROPE
 
 
 
 
 
 
7.1.2.3
ASIA PACIFIC
 
 
 
 
 
 
7.1.2.4
REST OF THE WORLD
 
 
 
 
7.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
7.3
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
7.4
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
 
 
 
 
 
8
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
Unlock AI-driven sequencing innovations with strategic patent insights and future-ready applications.
 
 
 
 
 
118
 
8.1
TECHNOLOGY ANALYSIS
 
 
 
 
 
 
 
8.1.1
KEY TECHNOLOGIES
 
 
 
 
 
 
 
8.1.1.1
SEQUENCING BY SYNTHESIS
 
 
 
 
 
 
8.1.1.2
ION SEMICONDUCTOR SEQUENCING
 
 
 
 
 
 
8.1.1.3
NANOPORE SEQUENCING
 
 
 
 
 
 
8.1.1.4
SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT)
 
 
 
 
 
8.1.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
8.1.2.1
AUTOMATED SAMPLE PREPARATION SYSTEMS
 
 
 
 
 
 
8.1.2.2
BIOINFORMATICS AND DATA ANALYSIS PLATFORMS
 
 
 
 
 
 
8.1.2.3
CRISPR-BASED TARGETED SEQUENCING
 
 
 
 
 
 
8.1.2.4
MULTIPLEX PCR
 
 
 
 
 
8.1.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
8.1.3.1
SINGLE-CELL SEQUENCING TECHNOLOGY
 
 
 
 
 
 
8.1.3.2
MULTIOMICS INTEGRATION
 
 
 
 
 
 
8.1.3.3
SPATIAL GENOMICS AND TRANSCRIPTOMICS
 
 
 
 
 
 
8.1.3.4
GENE EDITING TECHNOLOGIES
 
 
 
 
8.2
TECHNOLOGY ROADMAP
 
 
 
 
 
 
8.3
PATENT ANALYSIS
 
 
 
 
 
 
 
 
8.3.1
METHODOLOGY
 
 
 
 
 
 
8.3.2
NUMBER OF PATENTS FILED, BY DOCUMENT TYPE
 
 
 
 
 
 
8.3.3
LIST OF KEY PATENTS
 
 
 
 
 
8.4
FUTURE APPLICATIONS
 
 
 
 
 
 
8.5
IMPACT OF AI/GEN AI ON NEXT-GENERATION SEQUENCING MARKET
 
 
 
 
 
 
 
 
8.5.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
8.5.2
BEST PRACTICES IN AI-ENABLED NGS WORKFLOWS
 
 
 
 
 
 
8.5.3
CASE STUDIES OF AI IMPLEMENTATION IN NEXT-GENERATION SEQUENCING MARKET
 
 
 
 
 
 
8.5.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
8.5.5
CLIENTS’ READINESS TO ADOPT AI-INTEGRATED SEQUENCING SOLUTIONS IN NEXT-GENERATION SEQUENCING MARKET
 
 
 
 
9
NEXT-GENERATION SEQUENCING MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 15 Data Tables
 
 
 
 
 
130
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
PRODUCTS
 
 
 
 
 
 
 
9.2.1
DEMAND FOR CONSUMABLES AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL MARKET
 
 
 
 
 
9.3
SERVICES
 
 
 
 
 
 
 
9.3.1
SHIFT TOWARD SERVICE-BASED MODELS TO DRIVE MARKET
 
 
 
 
10
NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 91 Data Tables
 
 
 
 
 
138
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
CONSUMABLES
 
 
 
 
 
 
 
10.2.1
LIBRARY PREPARATION KITS & REAGENTS
 
 
 
 
 
 
 
10.2.1.1
STRONG DEMAND AND GROWING APPLICATIONS TO ENSURE MARKET GROWTH
 
 
 
 
 
10.2.2
SEQUENCING KITS & REAGENTS
 
 
 
 
 
 
 
10.2.2.1
FOCUS ON TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH
 
 
 
 
 
10.2.3
OTHER CONSUMABLES
 
 
 
 
 
10.3
PLATFORMS
 
 
 
 
 
 
 
10.3.1
SEQUENCING PLATFORMS
 
 
 
 
 
 
 
10.3.1.1
NEED FOR ADVANCED TECHNOLOGIES TO DECODE GENETIC INFORMATION TO DRIVE MARKET
 
 
 
 
 
 
10.3.1.2
ILLUMINA
 
 
 
 
 
 
 
 
10.3.1.2.1
NOVASEQ SERIES (X/X PLUS)
 
 
 
 
 
 
10.3.1.2.2
MISEQ/MISEQ I100
 
 
 
 
 
 
10.3.1.2.3
NEXTSEQ 1K/2K AND 550
 
 
 
 
 
 
10.3.1.2.4
NOVASEQ 6000
 
 
 
 
10.3.1.3
THERMO FISHER SCIENTIFIC
 
 
 
 
 
 
10.3.1.4
PACBIO
 
 
 
 
 
 
 
 
10.3.1.4.1
REVIO
 
 
 
 
 
 
10.3.1.4.2
SEQUEL II/IIE
 
 
 
 
 
 
10.3.1.4.3
VEGA SEQ
 
 
 
 
10.3.1.5
OXFORD NANOPORE TECHNOLOGIES
 
 
 
 
 
 
10.3.1.6
OTHER SEQUENCING PLATFORMS
 
 
 
 
 
10.3.2
LIBRARY PREPARATION PLATFORMS
 
 
 
 
 
 
 
10.3.2.1
RISING DEMAND FOR SEQUENCING IN CLINICAL APPLICATIONS TO DRIVE MARKET
 
 
 
 
10.4
BIOINFORMATICS TOOLS
 
 
 
 
 
 
 
10.4.1
DATA ANALYSIS SOFTWARE & WORKBENCHES
 
 
 
 
 
 
 
10.4.1.1
DEMAND FOR GENOME ANALYSIS IN CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH
 
 
 
 
 
10.4.2
DATA VISUALIZATION TOOLS
 
 
 
 
 
 
 
10.4.2.1
RISING DEMAND FOR SEQUENCING-BASED RESEARCH TO SUPPORT MARKET GROWTH
 
 
 
 
 
10.4.3
OTHER BIOINFORMATICS TOOLS
 
 
 
 
11
NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 37 Data Tables
 
 
 
 
 
188
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
SEQUENCING BY SYNTHESIS
 
 
 
 
 
 
 
11.2.1
HIGH, RAPID PRODUCTION OF BASE PAIRS TO SUPPORT ADOPTION
 
 
 
 
 
11.3
ION SEMICONDUCTOR SEQUENCING
 
 
 
 
 
 
 
11.3.1
SIMPLER WORKFLOW AND COST-EFFECTIVENESS TO SUPPORT MARKET GROWTH
 
 
 
 
 
11.4
SMRT SEQUENCING
 
 
 
 
 
 
 
11.4.1
FOCUS ON RAPID RESULTS AND LOWER SEQUENCING COSTS TO DRIVE MARKET
 
 
 
 
 
11.5
NANOPORE SEQUENCING
 
 
 
 
 
 
 
11.5.1
EMPHASIS ON DIRECT RNA SEQUENCING CAPABILITIES TO PROPEL DEMAND
 
 
 
 
 
11.6
OTHER SEQUENCING TECHNOLOGIES
 
 
 
 
 
12
NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY WORKFLOW
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 22 Data Tables
 
 
 
 
 
209
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
SEQUENCING
 
 
 
 
 
 
 
12.2.1
ABILITY TO ADDRESS COMPLEX GENOMIC REGIONS AND RESOLVE STRUCTURAL VARIATIONS TO DRIVE MARKET
 
 
 
 
 
12.3
PRESEQUENCING
 
 
 
 
 
 
 
12.3.1
INCREASED RESEARCH AND SUPPLY AGREEMENTS BETWEEN INDUSTRY PARTICIPANTS TO DRIVE MARKET
 
 
 
 
 
12.4
DATA ANALYSIS
 
 
 
 
 
 
 
12.4.1
RISE OF IN-HOUSE INSTALLATION OF BIOINFORMATICS INFRASTRUCTURE TO DRIVE MARKET
 
 
 
 
13
NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 29 Data Tables
 
 
 
 
 
222
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
 
13.2.1
RISING RESEARCH INTENSITY FOR GENOME RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH
 
 
 
 
 
13.3
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
13.3.1
RISING DEMAND FOR COMPREHENSIVE SEQUENCING DATA IN GENETIC RESEARCH TO DRIVE MARKET
 
 
 
 
 
13.4
CLINICAL & DIAGNOSTIC LABORATORIES
 
 
 
 
 
 
 
13.4.1
INCREASED APPLICATIONS IN DISEASE DIAGNOSTICS AND TREATMENT TO DRIVE MARKET GROWTH
 
 
 
 
 
13.5
OTHER END USERS
 
 
 
 
 
14
NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 123 Data Tables
 
 
 
 
 
238
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
SEQUENCING SERVICES
 
 
 
 
 
 
 
14.2.1
EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS
 
 
 
 
 
 
 
14.2.1.1
ADVANCEMENTS IN TARGET ENRICHMENT TECHNOLOGIES TO DRIVE MARKET
 
 
 
 
 
14.2.2
RNA SEQUENCING SERVICES
 
 
 
 
 
 
 
14.2.2.1
LAUNCH OF RNA SERVICES AND AVAILABILITY OF DIVERSE RNA BIOINFORMATICS TOOLS TO DRIVE MARKET
 
 
 
 
 
14.2.3
DE NOVO SEQUENCING SERVICES
 
 
 
 
 
 
 
14.2.3.1
NEED FOR MORE ACCURATE AND FASTER CHARACTERIZATION THAN TRADITIONAL METHODS TO DRIVE MARKET
 
 
 
 
 
14.2.4
CHIP SEQUENCING SERVICES
 
 
 
 
 
 
 
14.2.4.1
SURGE IN DEMAND FROM ACADEMIC AND RESEARCH INSTITUTES TO DRIVE MARKET
 
 
 
 
 
14.2.5
WHOLE-GENOME SEQUENCING SERVICES
 
 
 
 
 
 
 
14.2.5.1
TECHNOLOGICAL ADVANCEMENTS IN NEXT-GENERATION SEQUENCING PRODUCTS TO DRIVE MARKET
 
 
 
 
 
14.2.6
METHYL SEQUENCING SERVICES
 
 
 
 
 
 
 
14.2.6.1
LARGE-SCALE ADOPTION IN CANCER RESEARCH TO DRIVE MARKET
 
 
 
 
 
14.2.7
OTHER SEQUENCING SERVICES
 
 
 
 
 
14.3
PRESEQUENCING SERVICES
 
 
 
 
 
 
 
14.3.1
LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES
 
 
 
 
 
 
 
14.3.1.1
DEVELOPMENT OF ADVANCED LIBRARY PREPARATION SOLUTIONS TO DRIVE MARKET
 
 
 
 
 
14.3.2
SAMPLE PREPARATION SERVICES
 
 
 
 
 
 
 
14.3.2.1
APPLICABILITY IN ONCOLOGY, INFECTIOUS DISEASES, METAGENOMICS, AND EPIGENETICS TO DRIVE MARKET
 
 
 
 
 
14.3.3
QUALITY CONTROL SERVICES
 
 
 
 
 
 
 
14.3.3.1
GROWING RESEARCH ACTIVITIES USING NEXT-GENERATION SEQUENCING TECHNOLOGY TO DRIVE MARKET
 
 
 
 
14.4
BIOINFORMATICS & DATA ANALYSIS SERVICES
 
 
 
 
 
 
 
14.4.1
DATA ANALYSIS SERVICES
 
 
 
 
 
 
 
14.4.1.1
INCREASING DEMAND FOR PRECISION AND SPEED IN GENOMICS FOR CLINICAL DIAGNOSIS TO DRIVE MARKET
 
 
 
 
 
14.4.2
DATA VISUALIZATION & INTERPRETATION SERVICES
 
 
 
 
 
 
 
14.4.2.1
RISING DEMAND FOR SEQUENCING-BASED RESEARCH TO DRIVE MARKET
 
 
 
 
 
14.4.3
DATA STORAGE & MANAGEMENT SERVICES
 
 
 
 
 
 
 
14.4.3.1
NEED FOR EFFECTIVE DATA MANAGEMENT TO DRIVE MARKET
 
 
 
 
14.5
NGS PLATFORM SERVICES
 
 
 
 
 
 
 
14.5.1
COMPLIANCE WITH STRINGENT QUALITY AND OPERATIONAL REQUIREMENTS TO DRIVE MARKET
 
 
 
 
15
NEXT-GENERATION SEQUENCING SERVICES MARKET, BY WORKFLOW
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 22 Data Tables
 
 
 
 
 
298
 
15.1
INTRODUCTION
 
 
 
 
 
 
15.2
SEQUENCING
 
 
 
 
 
 
 
15.2.1
RISING DEMAND FOR SEQUENCING SERVICES AND APPLICATIONS IN CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH
 
 
 
 
 
15.3
PRESEQUENCING SERVICES
 
 
 
 
 
 
 
15.3.1
CUSTOM DEVELOPMENT OF SAMPLES FOR SEQUENCING TO BOOST MARKET GROWTH
 
 
 
 
 
15.4
DATA ANALYSIS SERVICES
 
 
 
 
 
 
 
15.4.1
RISING DEMAND FOR ADVANCED RESEARCH TO DRIVE MARKET
 
 
 
 
16
NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 29 Data Tables
 
 
 
 
 
310
 
16.1
INTRODUCTION
 
 
 
 
 
 
16.2
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
 
16.2.1
GROWING RESEARCH INTENSITY TO SUPPORT MARKET GROWTH
 
 
 
 
 
16.3
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
16.3.1
RISING DEMAND FOR COMPREHENSIVE GENETIC DATA TO DRIVE GROWTH
 
 
 
 
 
16.4
HOSPITALS & CLINICAL LABORATORIES
 
 
 
 
 
 
 
16.4.1
INCREASED APPLICATION IN NGS IN DISEASE DIAGNOSTICS AND TREATMENT TO DRIVE GROWTH
 
 
 
 
 
16.5
OTHER END USERS
 
 
 
 
 
17
NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 74 Data Tables
 
 
 
 
 
326
 
17.1
INTRODUCTION
 
 
 
 
 
 
17.2
DIAGNOSTICS
 
 
 
 
 
 
 
17.2.1
CANCER DIAGNOSTICS
 
 
 
 
 
 
 
17.2.1.1
RISING DEMAND FOR TARGETED THERAPIES TO DRIVE MARKET
 
 
 
 
 
17.2.2
INFECTIOUS DISEASE DIAGNOSTICS
 
 
 
 
 
 
 
17.2.2.1
RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL DIAGNOSTICS TO PROPEL GROWTH
 
 
 
 
 
17.2.3
REPRODUCTIVE HEALTH DIAGNOSTICS
 
 
 
 
 
 
 
17.2.3.1
FOCUS ON GENETIC DISEASE DIAGNOSTICS TO DRIVE GROWTH
 
 
 
 
 
17.2.4
OTHER DIAGNOSTIC APPLICATIONS
 
 
 
 
 
17.3
DRUG DISCOVERY & DEVELOPMENT
 
 
 
 
 
 
 
17.3.1
PHARMACOGENOMICS
 
 
 
 
 
 
 
17.3.1.1
RISING USE OF NGS FOR UNDERSTANDING GENOMIC VARIANTS IN HUMANS TO DRIVE GROWTH
 
 
 
 
 
17.3.2
OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS
 
 
 
 
 
17.4
AGRICULTURE & ANIMAL RESEARCH
 
 
 
 
 
 
 
17.4.1
EMPHASIS ON IMPROVING CROP PRODUCTIVITY TO DRIVE ADOPTION OF NGS
 
 
 
 
 
17.5
OTHER APPLICATIONS
 
 
 
 
 
18
NEXT-GENERATION SEQUENCING MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 17 Countries | 500 Data Tables.
 
 
 
 
 
362
 
18.1
INTRODUCTION
 
 
 
 
 
 
18.2
NORTH AMERICA
 
 
 
 
 
 
 
18.2.1
US
 
 
 
 
 
 
 
18.2.1.1
RAPID GROWTH AND ADVANCEMENTS TO LEAD MARKET
 
 
 
 
 
18.2.2
CANADA
 
 
 
 
 
 
 
18.2.2.1
INCREASING GOVERNMENT INITIATIVES IN SEQUENCING RESEARCH TO BOOST MARKET GROWTH
 
 
 
 
18.3
EUROPE
 
 
 
 
 
 
 
18.3.1
GERMANY
 
 
 
 
 
 
 
18.3.1.1
ADOPTION OF ADVANCED SEQUENCING TECHNOLOGIES TO DRIVE MARKET
 
 
 
 
 
18.3.2
UK
 
 
 
 
 
 
 
18.3.2.1
STRATEGIC INITIATIVES AND FUNDING FOR GENOMICS RESEARCH TO SUPPORT MARKET GROWTH
 
 
 
 
 
18.3.3
FRANCE
 
 
 
 
 
 
 
18.3.3.1
INCREASING GOVERNMENT INVESTMENT IN GENOMICS RESEARCH TO DRIVE GROWTH
 
 
 
 
 
18.3.4
ITALY
 
 
 
 
 
 
 
18.3.4.1
FAVORABLE FUNDING SCENARIO TO DRIVE ADOPTION OF ADVANCED SEQUENCING TECHNOLOGY
 
 
 
 
 
18.3.5
SPAIN
 
 
 
 
 
 
 
18.3.5.1
GROWING FOCUS ON ADVANCEMENTS IN PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH
 
 
 
 
 
18.3.6
NETHERLANDS
 
 
 
 
 
 
 
18.3.6.1
WELL-ESTABLISHED RESEARCH INFRASTRUCTURE TO SUSTAIN DEMAND FOR NGS
 
 
 
 
 
18.3.7
REST OF EUROPE
 
 
 
 
 
18.4
ASIA PACIFIC
 
 
 
 
 
 
 
18.4.1
CHINA
 
 
 
 
 
 
 
18.4.1.1
FAVORABLE REGULATORY REFORMS TO DRIVE MARKET
 
 
 
 
 
18.4.2
JAPAN
 
 
 
 
 
 
 
18.4.2.1
RISING NUMBER OF COLLABORATIONS IN NGS TO DRIVE MARKET
 
 
 
 
 
18.4.3
INDIA
 
 
 
 
 
 
 
18.4.3.1
GOVERNMENT AND PRIVATE INITIATIVES FOR GENOMICS PROJECTS TO PROPEL MARKET
 
 
 
 
 
18.4.4
AUSTRALIA
 
 
 
 
 
 
 
18.4.4.1
INCREASED GENETIC RESEARCH IN AUSTRALIA TO SUPPORT MARKET GROWTH
 
 
 
 
 
18.4.5
SOUTH KOREA
 
 
 
 
 
 
 
18.4.5.1
DEMAND FOR ADVANCED SEQUENCING TECHNOLOGIES TO SUPPORT MARKET
 
 
 
 
 
18.4.6
REST OF ASIA PACIFIC
 
 
 
 
 
18.5
LATIN AMERICA
 
 
 
 
 
 
 
18.5.1
BRAZIL
 
 
 
 
 
 
 
18.5.1.1
INCREASED GOVERNMENT INVESTMENTS IN GENOMICS ADVANCEMENTS TO DRIVE MARKET
 
 
 
 
 
18.5.2
MEXICO
 
 
 
 
 
 
 
18.5.2.1
RISING DEMAND FOR CHRONIC DISEASE TREATMENT TO SUPPORT GROWTH
 
 
 
 
 
18.5.3
REST OF LATIN AMERICA
 
 
 
 
 
18.6
MIDDLE EAST
 
 
 
 
 
 
 
18.6.1
GCC COUNTRIES
 
 
 
 
 
 
 
18.6.1.1
SAUDI ARABIA
 
 
 
 
 
 
 
 
18.6.1.1.1
GROWING HEALTHCARE EXPENDITURE IN SAUDI ARABIA TO BOOST MARKET GROWTH
 
 
 
 
18.6.1.2
UAE
 
 
 
 
 
 
 
 
18.6.1.2.1
COLLABORATIONS TO ADVANCE GENOME SEQUENCING AND MARKET GROWTH
 
 
 
 
18.6.1.3
REST OF GCC COUNTRIES
 
 
 
 
 
18.6.2
REST OF MIDDLE EAST
 
 
 
 
 
18.7
AFRICA
 
 
 
 
 
 
 
18.7.1
GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET
 
 
 
 
19
COMPETITIVE LANDSCAPE
Discover strategic insights and market dominance tactics of key players in the NGS industry.
 
 
 
 
 
574
 
19.1
INTRODUCTION
 
 
 
 
 
 
19.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
 
 
19.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NGS MARKET
 
 
 
 
 
19.3
REVENUE ANALYSIS, 2021–2025
 
 
 
 
 
 
 
19.4
MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
 
19.5
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
 
19.6
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
19.6.1
STARS
 
 
 
 
 
 
19.6.2
EMERGING LEADERS
 
 
 
 
 
 
19.6.3
PERVASIVE PLAYERS
 
 
 
 
 
 
19.6.4
PARTICIPANTS
 
 
 
 
 
 
19.6.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
19.6.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
19.6.5.2
REGION FOOTPRINT
 
 
 
 
 
 
19.6.5.3
OFFERING FOOTPRINT
 
 
 
 
 
 
19.6.5.4
APPLICATION FOOTPRINT
 
 
 
 
 
 
19.6.5.5
TECHNOLOGY FOOTPRINT
 
 
 
 
19.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
 
19.7.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
19.7.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
19.7.3
DYNAMIC COMPANIES
 
 
 
 
 
 
19.7.4
STARTING BLOCKS
 
 
 
 
 
 
19.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
19.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
19.7.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
 
 
 
 
19.8
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
 
 
19.8.1
COMPANY VALUATION
 
 
 
 
 
 
19.8.2
FINANCIAL METRICS
 
 
 
 
 
19.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
19.9.1
PRODUCT LAUNCHES
 
 
 
 
 
 
19.9.2
DEALS
 
 
 
 
 
 
19.9.3
EXPANSIONS
 
 
 
 
20
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
596
 
20.1
KEY PLAYERS
 
 
 
 
 
 
 
20.1.1
ILLUMINA, INC.
 
 
 
 
 
 
 
20.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
20.1.1.2
PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
20.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
20.1.1.3.1
PRODUCT LAUNCHES
 
 
 
 
 
 
20.1.1.3.2
DEALS
 
 
 
 
20.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
20.1.1.4.1
KEY STRENGTHS
 
 
 
 
 
 
20.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
20.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
 
 
 
20.1.2
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
 
 
20.1.3
AGILENT TECHNOLOGIES, INC.
 
 
 
 
 
 
20.1.4
F. HOFFMANN-LA ROCHE LTD.
 
 
 
 
 
 
20.1.5
QIAGEN
 
 
 
 
 
 
20.1.6
DANAHER CORPORATION
 
 
 
 
 
 
20.1.7
REVVITY
 
 
 
 
 
 
20.1.8
EUROFINS SCIENTIFIC
 
 
 
 
 
 
20.1.9
PACBIO
 
 
 
 
 
 
20.1.10
OXFORD NANOPORE TECHNOLOGIES PLC
 
 
 
 
 
 
20.1.11
TAKARA BIO INC.
 
 
 
 
 
 
20.1.12
BGI GROUP
 
 
 
 
 
 
20.1.13
BD
 
 
 
 
 
 
20.1.14
10X GENOMICS
 
 
 
 
 
 
20.1.15
PROMEGA CORPORATION
 
 
 
 
 
 
20.1.16
LGC LIMITED
 
 
 
 
 
 
20.1.17
WUXI BIOLOGICS
 
 
 
 
 
 
20.1.18
TECAN TRADING AG
 
 
 
 
 
 
20.1.19
TWIST BIOSCIENCE
 
 
 
 
 
 
20.1.20
AZENTA US INC.
 
 
 
 
 
20.2
OTHER PLAYERS
 
 
 
 
 
 
 
20.2.1
MGI TECH CO. LTD.
 
 
 
 
 
 
20.2.2
NOVOGENE CO., LTD.
 
 
 
 
 
 
20.2.3
NEW ENGLAND BIOLABS
 
 
 
 
 
 
20.2.4
GENSCRIPT
 
 
 
 
 
 
20.2.5
PSOMAGEN
 
 
 
 
 
 
20.2.6
ZYMO RESEARCH CORPORATION
 
 
 
 
 
 
20.2.7
HAMILTON COMPANY
 
 
 
 
 
 
20.2.8
NEOGENOMICS LABORATORIES
 
 
 
 
 
 
20.2.9
FULGENT GENETICS
 
 
 
 
 
 
20.2.10
SD BIOSENSOR, INC.
 
 
 
 
21
RESEARCH METHODOLOGY
 
 
 
 
 
691
 
21.1
RESEARCH DATA
 
 
 
 
 
 
 
21.1.1
SECONDARY DATA
 
 
 
 
 
 
 
21.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
21.1.2
PRIMARY DATA
 
 
 
 
 
 
 
21.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
21.1.2.2
KEY PRIMARY PARTICIPANTS
 
 
 
 
 
 
21.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
 
 
21.1.2.4
KEY INDUSTRY INSIGHTS
 
 
 
 
21.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
21.2.1
GLOBAL NEXT-GENERATION SEQUENCING MARKET ESTIMATION, 2025
 
 
 
 
 
 
21.2.2
SEGMENTAL MARKET SIZE ESTIMATION
 
 
 
 
 
21.3
MARKET GROWTH RATE PROJECTIONS
 
 
 
 
 
 
21.4
DATA TRIANGULATION
 
 
 
 
 
 
21.5
FACTOR ANALYSIS
 
 
 
 
 
 
21.6
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
21.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
 
 
 
 
 
22
APPENDIX
 
 
 
 
 
705
 
22.1
DISCUSSION GUIDE
 
 
 
 
 
 
22.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
22.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
22.4
RELATED REPORTS
 
 
 
 
 
 
22.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
NEXT-GENERATION SEQUENCING MARKET: INCLUSIONS & EXCLUSIONS
 
 
 
 
 
 
TABLE 2
IMPACT OF MARKET DYNAMICS
 
 
 
 
 
 
TABLE 3
NEXT-GENERATION SEQUENCING MARKET: PORTER’S FIVE FORCES
 
 
 
 
 
 
TABLE 4
NEXT-GENERATION SEQUENCING MARKET: ROLE OF PLAYERS IN ECOSYSTEM
 
 
 
 
 
 
TABLE 5
AVERAGE SELLING PRICE TREND OF PLATFORMS, BY KEY PLAYER, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 6
AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 7
AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2025 (USD)
 
 
 
 
 
 
TABLE 8
AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 9
IMPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 10
IMPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (TONS)
 
 
 
 
 
 
TABLE 11
EXPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 12
EXPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (TONS)
 
 
 
 
 
 
TABLE 13
IMPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 14
IMPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (TONS)
 
 
 
 
 
 
TABLE 15
EXPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 16
EXPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (TONS)
 
 
 
 
 
 
TABLE 17
NEXT-GENERATION SEQUENCING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2026–MARCH 2027
 
 
 
 
 
 
TABLE 18
RECIPROCAL TARIFF RATES ADJUSTED BY US
 
 
 
 
 
 
TABLE 19
CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES
 
 
 
 
 
 
TABLE 20
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE
 
 
 
 
 
 
TABLE 21
KEY BUYING CRITERIA FOR PRODUCTS, BY END USER
 
 
 
 
 
 
TABLE 22
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 23
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 24
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 25
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 26
NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015–2025
 
 
 
 
 
 
TABLE 27
KEY PATENTS, 2023–2025
 
 
 
 
 
 
TABLE 28
CASE STUDIES OF AI IMPLEMENTATION IN NEXT-GENERATION SEQUENCING MARKET
 
 
 
 
 
 
TABLE 29
CLIENT’S READINESS TO ADOPT AI-INTEGRATED SEQUENCING SOLUTIONS IN NEXT-GENERATION SEQUENCING MARKET
 
 
 
 
 
 
TABLE 30
NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 31
NGS PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 32
NORTH AMERICA: NGS PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 33
EUROPE: NGS PRODUCTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 34
ASIA PACIFIC: NGS PRODUCTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 35
LATIN AMERICA: NGS PRODUCTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 36
MIDDLE EAST: NGS PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 37
GCC COUNTRIES: NGS PRODUCTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 38
NGS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 39
NORTH AMERICA: NGS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 40
EUROPE: NGS SERVICES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
ASIA PACIFIC: NGS SERVICES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 42
LATIN AMERICA: NGS SERVICES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 43
MIDDLE EAST: NGS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 44
GCC COUNTRIES: NGS SERVICES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 46
NGS CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
NORTH AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 48
EUROPE: NGS CONSUMABLES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
ASIA PACIFIC: NGS CONSUMABLES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 50
LATIN AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 51
MIDDLE EAST: NGS CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 52
GCC COUNTRIES: NGS CONSUMABLES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 54
LIBRARY PREPARATION KITS & REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
NORTH AMERICA: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 56
EUROPE: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
ASIA PACIFIC: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 58
LATIN AMERICA: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 59
MIDDLE EAST: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY REGION/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 60
GCC COUNTRIES: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
SEQUENCING KITS & REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 62
NORTH AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 63
EUROPE: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 64
ASIA PACIFIC: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
LATIN AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 66
MIDDLE EAST: SEQUENCING KITS & REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
GCC COUNTRIES: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 68
OTHER CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 72
LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
MIDDLE EAST: OTHER CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
NGS PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 76
NORTH AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
EUROPE: NGS PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 78
ASIA PACIFIC: NGS PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
LATIN AMERICA: NGS PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 80
MIDDLE EAST: NGS PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
GCC COUNTRIES: NGS PLATFORMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 82
NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
SEQUENCING PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 84
NORTH AMERICA: SEQUENCING PLATFORMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 85
EUROPE: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 86
ASIA PACIFIC: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 87
LATIN AMERICA: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 88
MIDDLE EAST: SEQUENCING PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
GCC COUNTRIES: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 90
SEQUENCING PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
ILLUMINA SEQUENCING PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 92
ILLUMINA SEQUENCING PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
NOVASEQ (X/X PLUS) SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 94
MISEQ/MISEQ I100 SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
NEXTSEQ 1K/2K AND 550 SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 96
NOVASEQ 6000 SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
THERMO FISHER SCIENTIFIC SEQUENCING PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 98
PACBIO SEQUENCING PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
OXFORD NANOPORE TECHNOLOGIES SEQUENCING PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 100
LIBRARY PREPARATION PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
NORTH AMERICA: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
EUROPE: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
ASIA PACIFIC: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
LATIN AMERICA: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
MIDDLE EAST: LIBRARY PREPARATION PLATFORMS MARKET, BY REGION/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 106
GCC COUNTRIES: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 107
NGS BIOINFORMATICS TOOLS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
NORTH AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 110
ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 114
NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 116
NORTH AMERICA: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
EUROPE: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 118
ASIA PACIFIC: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
LATIN AMERICA: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
MIDDLE EAST: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
GCC COUNTRIES: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
DATA VISUALIZATION TOOLS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
NORTH AMERICA: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
EUROPE: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
ASIA PACIFIC: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
LATIN AMERICA: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
MIDDLE EAST: DATA VISUALIZATION TOOLS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
GCC COUNTRIES: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
OTHER BIOINFORMATICS TOOLS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
NORTH AMERICA: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
EUROPE: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
ASIA PACIFIC: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
LATIN AMERICA: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
MIDDLE EAST: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
GCC COUNTRIES: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
NGS TECHNOLOGIES, BY COMPANY
 
 
 
 
 
 
TABLE 137
NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
NORTH AMERICA: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
EUROPE: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
ASIA PACIFIC: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 142
LATIN AMERICA: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
MIDDLE EAST: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
GCC COUNTRIES: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
NORTH AMERICA: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
EUROPE: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
ASIA PACIFIC: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
LATIN AMERICA: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
MIDDLE EAST: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
GCC COUNTRIES: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
NORTH AMERICA: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
EUROPE: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
ASIA PACIFIC: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 156
LATIN AMERICA: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
MIDDLE EAST: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
GCC COUNTRIES: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
NORTH AMERICA: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
EUROPE: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
ASIA PACIFIC: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
LATIN AMERICA: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 164
MIDDLE EAST: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
GCC COUNTRIES: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
NORTH AMERICA: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
EUROPE: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
ASIA PACIFIC: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
LATIN AMERICA: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
MIDDLE EAST: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
GCC COUNTRIES: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
NORTH AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
EUROPE: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
ASIA PACIFIC: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 178
LATIN AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
MIDDLE EAST: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 180
GCC COUNTRIES: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 182
NORTH AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
EUROPE: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 184
ASIA PACIFIC: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
LATIN AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 186
MIDDLE EAST: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 187
GCC COUNTRIES: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 188
NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
NORTH AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 190
EUROPE: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
ASIA PACIFIC: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 192
LATIN AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
MIDDLE EAST: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 194
GCC COUNTRIES: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 195
NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 196
NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 197
NORTH AMERICA: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 198
EUROPE: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
ASIA PACIFIC: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 200
LATIN AMERICA: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
MIDDLE EAST: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 202
GCC COUNTRIES: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 204
NORTH AMERICA: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
EUROPE: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 206
ASIA PACIFIC: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 207
LATIN AMERICA: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 208
MIDDLE EAST: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
GCC COUNTRIES: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 210
NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 211
NORTH AMERICA: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 212
EUROPE: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
ASIA PACIFIC: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 214
LATIN AMERICA: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
MIDDLE EAST: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 216
GCC COUNTRIES: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
NGS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 218
NORTH AMERICA: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
EUROPE: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 220
ASIA PACIFIC: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 221
LATIN AMERICA: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 222
MIDDLE EAST: NGS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
GCC COUNTRIES: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 224
NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 226
NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 227
EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 228
ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 230
MIDDLE EAST: SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 231
GCC COUNTRIES: SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 232
SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 233
EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 234
NORTH AMERICA: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 235
EUROPE: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 236
ASIA PACIFIC: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 237
LATIN AMERICA: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 238
MIDDLE EAST: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 239
GCC COUNTRIES: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 240
RNA SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 241
NORTH AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 242
EUROPE: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 243
ASIA PACIFIC: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 244
LATIN AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 245
MIDDLE EAST: RNA SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 246
GCC COUNTRIES: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 247
DE NOVO SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 248
NORTH AMERICA: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 249
EUROPE: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 250
ASIA PACIFIC: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 251
LATIN AMERICA: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 252
MIDDLE EAST: DE NOVO SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 253
GCC COUNTRIES: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 254
CHIP SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 255
NORTH AMERICA: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 256
EUROPE: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 257
ASIA PACIFIC: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 258
LATIN AMERICA: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 259
MIDDLE EAST: CHIP SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 260
GCC COUNTRIES: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 261
WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 262
NORTH AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 263
EUROPE: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 264
ASIA PACIFIC: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 265
LATIN AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 266
MIDDLE EAST: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 267
GCC COUNTRIES: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 268
METHYL SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 269
NORTH AMERICA: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 270
EUROPE: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 271
ASIA PACIFIC: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 272
LATIN AMERICA: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 273
MIDDLE EAST: METHYL SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 274
GCC COUNTRIES: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 275
OTHER SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 276
NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 277
EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 278
ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 279
LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 280
MIDDLE EAST: OTHER SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 281
GCC COUNTRIES: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 282
PRESEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 283
NORTH AMERICA: PRESEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 284
EUROPE: PRESEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 285
ASIA PACIFIC: PRESEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 286
LATIN AMERICA: PRESEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 287
MIDDLE EAST: PRESEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 288
GCC COUNTRIES: PRESEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 289
PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 290
LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 291
NORTH AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 292
EUROPE: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 293
ASIA PACIFIC: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 294
LATIN AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 295
MIDDLE EAST: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 296
GCC COUNTRIES: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 297
SAMPLE PREPARATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 298
NORTH AMERICA: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 299
EUROPE: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 300
ASIA PACIFIC: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 301
LATIN AMERICA: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 302
MIDDLE EAST: SAMPLE PREPARATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 303
GCC COUNTRIES: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 304
QUALITY CONTROL SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 305
NORTH AMERICA: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 306
EUROPE: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 307
ASIA PACIFIC: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 308
LATIN AMERICA: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 309
MIDDLE EAST: QUALITY CONTROL SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 310
GCC COUNTRIES: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 311
BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 312
NORTH AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 313
EUROPE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 314
ASIA PACIFIC: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 315
LATIN AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 316
MIDDLE EAST: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 317
GCC COUNTRIES: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 318
BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 319
DATA ANALYSIS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 320
NORTH AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 321
EUROPE: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 322
ASIA PACIFIC: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 323
LATIN AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 324
MIDDLE EAST: DATA ANALYSIS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 325
GCC COUNTRIES: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 326
DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 327
NORTH AMERICA: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 328
EUROPE: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 329
ASIA PACIFIC: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 330
LATIN AMERICA: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 331
MIDDLE EAST: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 332
GCC COUNTRIES: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 333
DATA STORAGE & MANAGEMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 334
NORTH AMERICA: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 335
EUROPE: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 336
ASIA PACIFIC: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 337
LATIN AMERICA: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 338
MIDDLE EAST: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 339
GCC COUNTRIES: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 340
NGS PLATFORM SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 341
NORTH AMERICA: NGS PLATFORM SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 342
EUROPE: NGS PLATFORM SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 343
ASIA PACIFIC: NGS PLATFORM SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 344
LATIN AMERICA: NGS PLATFORM SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 345
MIDDLE EAST: NGS PLATFORM SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 346
GCC COUNTRIES: NGS PLATFORM SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 347
NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 348
NGS SERVICES MARKET FOR SEQUENCING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 349
NORTH AMERICA: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 350
EUROPE: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 351
ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 352
LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 353
MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 354
GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 355
NGS SERVICES MARKET FOR PRESEQUENCING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 356
NORTH AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 357
EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 358
ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 359
LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 360
MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 361
GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 362
NGS SERVICES MARKET FOR DATA ANALYSIS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 363
NORTH AMERICA: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 364
EUROPE: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 365
ASIA PACIFIC: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 366
LATIN AMERICA: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 367
MIDDLE EAST: NGS SERVICES MARKET FOR DATA ANALYSIS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 368
GCC COUNTRIES: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 369
NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 370
NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 371
NORTH AMERICA: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 372
EUROPE: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 373
ASIA PACIFIC: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 374
LATIN AMERICA: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 375
MIDDLE EAST: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 376
GCC COUNTRIES: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 377
NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 378
NORTH AMERICA: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 379
EUROPE: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 380
ASIA PACIFIC: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 381
LATIN AMERICA: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 382
MIDDLE EAST: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 383
GCC COUNTRIES: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 384
NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 385
NORTH AMERICA: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 386
EUROPE: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 387
ASIA PACIFIC: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 388
LATIN AMERICA: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 389
MIDDLE EAST: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 390
GCC COUNTRIES: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY/REGION 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 391
NGS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 392
NORTH AMERICA: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 393
EUROPE: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 394
ASIA PACIFIC: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 395
LATIN AMERICA: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 396
MIDDLE EAST: NGS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 397
GCC COUNTRIES: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 398
NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 399
NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 400
NORTH AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 401
EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 402
ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 403
LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 404
MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 405
GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 406
NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 407
FUNDING AND GRANTS FOR CANCER RESEARCH, BY TYPE (AS OF JANUARY 2023)
 
 
 
 
 
 
TABLE 408
CANCER DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 409
NORTH AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 410
EUROPE: CANCER DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 411
ASIA PACIFIC: CANCER DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 412
LATIN AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 413
MIDDLE EAST: CANCER DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 414
GCC COUNTRIES: CANCER DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 415
INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 416
NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 417
EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 418
ASIA PACIFIC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 419
LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 420
MIDDLE EAST: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 421
GCC COUNTRIES: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 422
REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 423
NORTH AMERICA: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 424
EUROPE: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 425
ASIA PACIFIC: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 426
LATIN AMERICA: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 427
MIDDLE EAST: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 428
GCC COUNTRIES: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 429
OTHER DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 430
NORTH AMERICA: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 431
EUROPE: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 432
ASIA PACIFIC: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 433
LATIN AMERICA: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 434
MIDDLE EAST: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 435
GCC COUNTRIES: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 436
NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 437
NORTH AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 438
EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 439
ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 440
LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 441
MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 442
GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 443
NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 444
PHARMACOGENOMICS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 445
NORTH AMERICA: PHARMACOGENOMICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 446
EUROPE: PHARMACOGENOMICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 447
ASIA PACIFIC: PHARMACOGENOMICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 448
LATIN AMERICA: PHARMACOGENOMICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 449
MIDDLE EAST: PHARMACOGENOMICS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 450
GCC COUNTRIES: PHARMACOGENOMICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 451
OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 452
NORTH AMERICA: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 453
EUROPE: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 454
ASIA PACIFIC: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 455
LATIN AMERICA: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 456
MIDDLE EAST: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 457
GCC COUNTRIES: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 458
AGRICULTURE & ANIMAL RESEARCH MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 459
NORTH AMERICA: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 460
EUROPE: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 461
ASIA PACIFIC: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 462
LATIN AMERICA: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 463
MIDDLE EAST: AGRICULTURE & ANIMAL RESEARCH MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 464
GCC COUNTRIES: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 465
OTHER APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 466
NORTH AMERICA: OTHER APPLICATIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 467
EUROPE: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 468
ASIA PACIFIC: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 469
LATIN AMERICA: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 470
MIDDLE EAST: OTHER APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 471
GCC COUNTRIES: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 472
NGS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 473
NORTH AMERICA: NGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 474
NORTH AMERICA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 475
NORTH AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 476
NORTH AMERICA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 477
NORTH AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 478
NORTH AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 479
NORTH AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 480
NORTH AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 481
NORTH AMERICA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 482
NORTH AMERICA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 483
NORTH AMERICA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 484
NORTH AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 485
NORTH AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 486
NORTH AMERICA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 487
NORTH AMERICA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 488
NORTH AMERICA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 489
NORTH AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 490
NORTH AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 491
US: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 492
US: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 493
US: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 494
US: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 495
US: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 496
US: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 497
US: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 498
US: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 499
US: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 500
US: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 501
US: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 502
US: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 503
US: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 504
US: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 505
US: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 506
US: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 507
US: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 508
CANADA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 509
CANADA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 510
CANADA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 511
CANADA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 512
CANADA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 513
CANADA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 514
CANADA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 515
CANADA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 516
CANADA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 517
CANADA: PRESEQUENCING SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 518
CANADA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 519
CANADA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 520
CANADA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 521
CANADA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 522
CANADA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 523
CANADA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 524
CANADA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 525
EUROPE: NGS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 526
EUROPE: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 527
EUROPE: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 528
EUROPE: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 529
EUROPE: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 530
EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 531
EUROPE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 532
EUROPE: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 533
EUROPE: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 534
EUROPE: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 535
EUROPE: PRESEQUENCING SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 536
EUROPE: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 537
EUROPE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 538
EUROPE: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 539
EUROPE: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 540
EUROPE: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 541
EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 542
EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 543
GERMANY: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 544
GERMANY: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 545
GERMANY: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 546
GERMANY: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 547
GERMANY: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 548
GERMANY: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 549
GERMANY: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 550
GERMANY: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 551
GERMANY: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 552
GERMANY: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 553
GERMANY: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 554
GERMANY: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 555
GERMANY: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 556
GERMANY: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 557
GERMANY: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 558
GERMANY: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 559
GERMANY: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 560
UK: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 561
UK: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 562
UK: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 563
UK: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 564
UK: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 565
UK: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 566
UK: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 567
UK: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 568
UK: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 569
UK: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 570
UK: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 571
UK: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 572
UK: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 573
UK: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 574
UK: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 575
UK: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 576
UK: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 577
FRANCE: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 578
FRANCE: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 579
FRANCE: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 580
FRANCE: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 581
FRANCE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 582
FRANCE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 583
FRANCE: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 584
FRANCE: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 585
FRANCE: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 586
FRANCE: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 587
FRANCE: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 588
FRANCE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 589
FRANCE: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 590
FRANCE: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 591
FRANCE: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 592
FRANCE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 593
FRANCE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 594
ITALY: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 595
ITALY: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 596
ITALY: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 597
ITALY: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 598
ITALY: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 599
ITALY: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 600
ITALY: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 601
ITALY: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 602
ITALY: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 603
ITALY: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 604
ITALY: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 605
ITALY: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 606
ITALY: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 607
ITALY: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 608
ITALY: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 609
ITALY: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 610
ITALY: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 611
SPAIN: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 612
SPAIN: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 613
SPAIN: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 614
SPAIN: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 615
SPAIN: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 616
SPAIN: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 617
SPAIN: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 618
SPAIN: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 619
SPAIN: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 620
SPAIN: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 621
SPAIN: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 622
SPAIN: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 623
SPAIN: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 624
SPAIN: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 625
SPAIN: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 626
SPAIN: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 627
SPAIN: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 628
NETHERLANDS: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 629
NETHERLANDS: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 630
NETHERLANDS: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 631
NETHERLANDS: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 632
NETHERLANDS: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 633
NETHERLANDS: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 634
NETHERLANDS: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 635
NETHERLANDS: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 636
NETHERLANDS: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 637
NETHERLANDS: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 638
NETHERLANDS: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 639
NETHERLANDS: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 640
NETHERLANDS: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 641
NETHERLANDS: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 642
NETHERLANDS: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 643
NETHERLANDS: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 644
NETHERLANDS: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 645
REST OF EUROPE: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 646
REST OF EUROPE: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 647
REST OF EUROPE: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 648
REST OF EUROPE: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 649
REST OF EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 650
REST OF EUROPE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 651
REST OF EUROPE: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 652
REST OF EUROPE: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 653
REST OF EUROPE: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 654
REST OF EUROPE: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 655
REST OF EUROPE: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 656
REST OF EUROPE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 657
REST OF EUROPE: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 658
REST OF EUROPE: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 659
REST OF EUROPE: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 660
REST OF EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 661
REST OF EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 662
ASIA PACIFIC: NGS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 663
ASIA PACIFIC: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 664
ASIA PACIFIC: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 665
ASIA PACIFIC: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 666
ASIA PACIFIC: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 667
ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 668
ASIA PACIFIC: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 669
ASIA PACIFIC: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 670
ASIA PACIFIC: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 671
ASIA PACIFIC: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 672
ASIA PACIFIC: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 673
ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 674
ASIA PACIFIC: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 675
ASIA PACIFIC: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 676
ASIA PACIFIC: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 677
ASIA PACIFIC: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 678
ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 679
ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 680
CHINA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 681
CHINA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 682
CHINA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 683
CHINA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 684
CHINA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 685
CHINA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 686
CHINA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 687
CHINA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 688
CHINA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 689
CHINA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 690
CHINA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 691
CHINA: FOR BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 692
CHINA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 693
CHINA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 694
CHINA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 695
CHINA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 696
CHINA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 697
JAPAN: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 698
JAPAN: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 699
JAPAN: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 700
JAPAN: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 701
JAPAN: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 702
JAPAN: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 703
JAPAN: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 704
JAPAN: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 705
JAPAN: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 706
JAPAN: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 707
JAPAN: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 708
JAPAN: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 709
JAPAN: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 710
JAPAN: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 711
JAPAN: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 712
JAPAN: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 713
JAPAN: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 714
INDIA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 715
INDIA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 716
INDIA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 717
INDIA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 718
INDIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 719
INDIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 720
INDIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 721
INDIA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 722
INDIA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 723
INDIA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 724
INDIA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 725
INDIA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 726
INDIA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 727
INDIA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 728
INDIA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 729
INDIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 730
INDIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 731
AUSTRALIA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 732
AUSTRALIA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 733
AUSTRALIA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 734
AUSTRALIA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 735
AUSTRALIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 736
AUSTRALIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 737
AUSTRALIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 738
AUSTRALIA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 739
AUSTRALIA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 740
AUSTRALIA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 741
AUSTRALIA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 742
AUSTRALIA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 743
AUSTRALIA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 744
AUSTRALIA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 745
AUSTRALIA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 746
AUSTRALIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 747
AUSTRALIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 748
SOUTH KOREA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 749
SOUTH KOREA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 750
SOUTH KOREA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 751
SOUTH KOREA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 752
SOUTH KOREA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 753
SOUTH KOREA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 754
SOUTH KOREA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 755
SOUTH KOREA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 756
SOUTH KOREA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 757
SOUTH KOREA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 758
SOUTH KOREA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 759
SOUTH KOREA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 760
SOUTH KOREA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 761
SOUTH KOREA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 762
SOUTH KOREA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 763
SOUTH KOREA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 764
SOUTH KOREA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 765
REST OF ASIA PACIFIC: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 766
REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 767
REST OF ASIA PACIFIC: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 768
REST OF ASIA PACIFIC: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 769
REST OF ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 770
REST OF ASIA PACIFIC: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 771
REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 772
REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 773
REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 774
REST OF ASIA PACIFIC: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 775
REST OF ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 776
REST OF ASIA PACIFIC: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 777
REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 778
REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 779
REST OF ASIA PACIFIC: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 780
REST OF ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 781
REST OF ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 782
LATIN AMERICA: NGS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 783
LATIN AMERICA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 784
LATIN AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 785
LATIN AMERICA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 786
LATIN AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 787
LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 788
LATIN AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 789
LATIN AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 790
LATIN AMERICA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 791
LATIN AMERICA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 792
LATIN AMERICA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 793
LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 794
LATIN AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 795
LATIN AMERICA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 796
LATIN AMERICA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 797
LATIN AMERICA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 798
LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 799
LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 800
BRAZIL: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 801
BRAZIL: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 802
BRAZIL: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 803
BRAZIL: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 804
BRAZIL: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 805
BRAZIL: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 806
BRAZIL: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 807
BRAZIL: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 808
BRAZIL: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 809
BRAZIL: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 810
BRAZIL: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 811
BRAZIL: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 812
BRAZIL: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 813
BRAZIL: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 814
BRAZIL: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 815
BRAZIL: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 816
BRAZIL: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 817
MEXICO: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 818
MEXICO: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 819
MEXICO: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 820
MEXICO: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 821
MEXICO: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 822
MEXICO: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 823
MEXICO: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 824
MEXICO: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 825
MEXICO: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 826
MEXICO: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 827
MEXICO: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 828
MEXICO: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 829
MEXICO: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 830
MEXICO: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 831
MEXICO: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 832
MEXICO: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 833
MEXICO: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 834
REST OF LATIN AMERICA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 835
REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 836
REST OF LATIN AMERICA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 837
REST OF LATIN AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 838
REST OF LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 839
REST OF LATIN AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 840
REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 841
REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 842
REST OF LATIN AMERICA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 843
REST OF LATIN AMERICA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 844
REST OF LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 845
REST OF LATIN AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 846
REST OF LATIN AMERICA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 847
REST OF LATIN AMERICA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 848
REST OF LATIN AMERICA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 849
REST OF LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 850
REST OF LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 851
MIDDLE EAST: NGS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 852
MIDDLE EAST: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 853
MIDDLE EAST: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 854
MIDDLE EAST: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 855
MIDDLE EAST: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 856
MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 857
MIDDLE EAST: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 858
MIDDLE EAST: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 859
MIDDLE EAST: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 860
MIDDLE EAST: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 861
MIDDLE EAST: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 862
MIDDLE EAST: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 863
MIDDLE EAST: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 864
MIDDLE EAST: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 865
MIDDLE EAST: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 866
MIDDLE EAST: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 867
MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 868
MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 869
GCC COUNTRIES: NGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 870
GCC COUNTRIES: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 871
GCC COUNTRIES: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 872
GCC COUNTRIES: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 873
GCC COUNTRIES: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 874
GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 875
GCC COUNTRIES: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 876
GCC COUNTRIES: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 877
GCC COUNTRIES: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 878
GCC COUNTRIES: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 879
GCC COUNTRIES: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 880
GCC COUNTRIES: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 881
GCC COUNTRIES: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 882
GCC COUNTRIES: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 883
GCC COUNTRIES: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 884
GCC COUNTRIES: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 885
GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 886
GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 887
SAUDI ARABIA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 888
SAUDI ARABIA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 889
SAUDI ARABIA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 890
SAUDI ARABIA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 891
SAUDI ARABIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 892
SAUDI ARABIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 893
SAUDI ARABIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 894
SAUDI ARABIA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 895
SAUDI ARABIA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 896
SAUDI ARABIA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 897
SAUDI ARABIA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 898
SAUDI ARABIA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 899
SAUDI ARABIA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 900
SAUDI ARABIA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 901
SAUDI ARABIA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 902
SAUDI ARABIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 903
SAUDI ARABIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 904
UAE: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 905
UAE: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 906
UAE: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 907
UAE: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 908
UAE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 909
UAE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 910
UAE: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 911
UAE: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 912
UAE: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 913
UAE: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 914
UAE: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 915
UAE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 916
UAE: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 917
UAE: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 918
UAE: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 919
UAE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 920
UAE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 921
REST OF GCC COUNTRIES: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 922
REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 923
REST OF GCC COUNTRIES: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 924
REST OF GCC COUNTRIES: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 925
REST OF GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 926
REST OF GCC COUNTRIES: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 927
REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 928
REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 929
REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 930
REST OF GCC COUNTRIES: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 931
REST OF GCC COUNTRIES: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 932
REST OF GCC COUNTRIES: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 933
REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 934
REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 935
REST OF GCC COUNTRIES: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 936
REST OF GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 937
REST OF GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 938
REST OF MIDDLE EAST: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 939
REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 940
REST OF MIDDLE EAST: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 941
REST OF MIDDLE EAST: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 942
REST OF MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 943
REST OF MIDDLE EAST: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 944
REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 945
REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 946
REST OF MIDDLE EAST: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 947
REST OF MIDDLE EAST: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 948
REST OF MIDDLE EAST: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 949
REST OF MIDDLE EAST: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 950
REST OF MIDDLE EAST: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 951
REST OF MIDDLE EAST: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 952
REST OF MIDDLE EAST: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 953
REST OF MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 954
REST OF MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 955
AFRICA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 956
AFRICA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 957
AFRICA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 958
AFRICA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 959
AFRICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 960
AFRICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 961
AFRICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 962
AFRICA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 963
AFRICA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 964
AFRICA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 965
AFRICA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 966
AFRICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 967
AFRICA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 968
AFRICA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 969
AFRICA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 970
AFRICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 971
AFRICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 972
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 973
NGS MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 974
NGS MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 975
NGS MARKET: OFFERING FOOTPRINT
 
 
 
 
 
 
TABLE 976
NGS MARKET: APPLICATION FOOTPRINT
 
 
 
 
 
 
TABLE 977
NGS PLATFORMS MARKET: TECHNOLOGY FOOTPRINT
 
 
 
 
 
 
TABLE 978
NGS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 979
NGS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
 
 
 
 
 
 
TABLE 980
NGS MARKET: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 981
NGS MARKET: DEALS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 982
NGS MARKET: EXPANSIONS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 983
ILLUMINA, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 984
ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 985
ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 986
ILLUMINA, INC.: DEALS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 987
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 988
THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 989
THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 990
THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 991
THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 992
AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 993
AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 994
AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 995
AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 996
AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 997
F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 998
F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 999
F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1000
F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1001
F. HOFFMANN-LA ROCHE LTD.: OTHER DEVELOPMENTS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1002
QIAGEN: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1003
QIAGEN: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 1004
QIAGEN: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1005
QIAGEN: DEALS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1006
QIAGEN: EXPANSIONS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1007
DANAHER CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1008
DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 1009
DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1010
DANAHER CORPORATION: DEALS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1011
DANAHER CORPORATION: EXPANSIONS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1012
REVVITY: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1013
REVVITY: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 1014
REVVITY: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1015
REVVITY: DEALS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1016
REVVITY: EXPANSIONS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1017
EUROFINS SCIENTIFIC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1018
EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 1019
EUROFINS SCIENTIFIC: DEALS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1020
PACBIO: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1021
PACBIO: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 1022
PACBIO: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1023
PACBIO: DEALS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1024
PACBIO: EXPANSIONS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1025
OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1026
OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 1027
OXFORD NANOPORE TECHNOLOGIES PLC: DEALS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1028
OXFORD NANOPORE TECHNOLOGIES PLC: EXPANSIONS, JANUARY 2023-JANUARY 2026
 
 
 
 
 
 
TABLE 1029
TAKARA BIO INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1030
TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 1031
TAKARA BIO INC.: DEALS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1032
BGI GROUP: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1033
BGI GROUP: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 1034
BD: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1035
BD: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 1036
BD: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1037
10X GENOMICS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1038
10X GENOMICS: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 1039
PROMEGA CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1040
PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 1041
LGC LIMITED: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1042
LGC LIMITED: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 1043
LGC LIMITED: DEALS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1044
WUXI BIOLOGICS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1045
WUXI BIOLOGICS: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 1046
TECAN TRADING AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1047
TECAN TRADING AG: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 1048
TECAN TRADING AG: DEALS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1049
TWIST BIOSCIENCE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1050
TWIST BIOSCIENCE: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 1051
TWIST BIOSCIENCE: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1052
TWIST BIOSCIENCE: DEALS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1053
AZENTA US INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1054
AZENTA US INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 1055
AZENTA US INC.: DEALS, JANUARY 2023–JANUARY 2026
 
 
 
 
 
 
TABLE 1056
IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
 
 
 
 
 
 
TABLE 1057
RISK ASSESSMENT
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
NEXT-GENERATION SEQUENCING MARKET SEGMENTATION AND REGIONAL SCOPE
 
 
 
 
 
 
FIGURE 2
NEXT-GENERATION SEQUENCING MARKET: YEARS CONSIDERED
 
 
 
 
 
 
FIGURE 3
MARKET SCENARIO
 
 
 
 
 
 
FIGURE 4
GLOBAL NEXT-GENERATION SEQUENCING MARKET, 2024–2031
 
 
 
 
 
 
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NEXT-GENERATION SEQUENCING MARKET
 
 
 
 
 
 
FIGURE 6
DISRUPTIONS INFLUENCING GROWTH OF NEXT-GENERATION SEQUENCING MARKET
 
 
 
 
 
 
FIGURE 7
HIGH-GROWTH SEGMENTS IN NEXT-GENERATION SEQUENCING MARKET
 
 
 
 
 
 
FIGURE 8
ASIA PACIFIC TO BE FASTEST-GROWING REGION DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 9
ADVANCEMENTS IN SEQUENCING PLATFORMS TO DRIVE MARKET GROWTH
 
 
 
 
 
 
FIGURE 10
PRODUCTS OFFERING AND US LED NORTH AMERICA’S NEXT-GENERATION SEQUENCING MARKET IN 2025
 
 
 
 
 
 
FIGURE 11
CHINA TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 12
PRODUCTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 13
NEXT-GENERATION SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 14
NEXT-GENERATION SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 15
GROWTH OF GLOBAL GDP, 2020–2024
 
 
 
 
 
 
FIGURE 16
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 17
NEXT-GENERATION SEQUENCING MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 18
AVERAGE SELLING PRICE OF PLATFORMS, BY KEY PLAYER, 2025 (USD)
 
 
 
 
 
 
FIGURE 19
AVERAGE SELLING PRICE OF CONSUMABLES, BY KEY PLAYER, 2025 (USD)
 
 
 
 
 
 
FIGURE 20
AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2025 (USD)
 
 
 
 
 
 
FIGURE 21
AVERAGE SELLING PRICE, BY REGION, 2025 (USD)
 
 
 
 
 
 
FIGURE 22
NEXT-GENERATION SEQUENCING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
FIGURE 23
INVESTMENT & FUNDING SCENARIO, 2023–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 24
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
 
 
 
 
 
 
FIGURE 25
KEY BUYING CRITERIA FOR NGS PRODUCTS, BY END USER
 
 
 
 
 
 
FIGURE 26
PATENT APPLICATIONS IN NEXT-GENERATION SEQUENCING MARKET, JANUARY 2015–DECEMBER 2025
 
 
 
 
 
 
FIGURE 27
IMPACT OF AI/GEN AI ON NEXT-GENERATION SEQUENCING MARKET
 
 
 
 
 
 
FIGURE 28
NOVASEQ SERIES (X/X PLUS) PLATFORM SHIPMENTS, 2023–2025 (UNITS)
 
 
 
 
 
 
FIGURE 29
MISEQ/MISEQ I100 PLATFORM SHIPMENTS, 2023–2025 (UNITS)
 
 
 
 
 
 
FIGURE 30
NEXTSEQ 1K/2K AND 550 PLATFORM SHIPMENTS, 2023–2025 (UNITS)
 
 
 
 
 
 
FIGURE 31
NOVASEQ 6000 PLATFORM SHIPMENTS, 2023–2025 (UNITS)
 
 
 
 
 
 
FIGURE 32
REVIO PLATFORM REVENUE, 2023–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 33
REVIO PLATFORM SHIPMENTS, 2023–2025 (UNITS)
 
 
 
 
 
 
FIGURE 34
SEQUEL II/IIE PLATFORM REVENUE, 2023–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 35
SEQUEL II/IIE PLATFORM SHIPMENTS, 2023–2025 (UNITS)
 
 
 
 
 
 
FIGURE 36
VEGA SEQ PLATFORM REVENUE, 2023–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 37
VEGA SEQ PLATFORM SHIPMENTS, 2023–2025 (UNITS)
 
 
 
 
 
 
FIGURE 38
NORTH AMERICA: NGS MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 39
ASIA PACIFIC: NGS MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 40
REVENUE ANALYSIS OF KEY PLAYERS, 2021–2025 (USD BILLION)
 
 
 
 
 
 
FIGURE 41
MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
FIGURE 42
NGS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
 
 
FIGURE 43
NGS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 44
NGS MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 45
NGS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 46
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 47
EV/EBITDA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 48
ILLUMINA, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 49
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 50
AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 51
F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 52
QIAGEN: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 53
DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 54
REVVITY: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 55
EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 56
PACBIO: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 57
OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 58
TAKARA BIO INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 59
BD: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 60
10X GENOMICS: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 61
LGC LIMITED: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 62
WUXI BIOLOGICS: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 63
TECAN TRADING AG: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 64
TWIST BIOSCIENCE: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 65
AZENTA US INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 66
NEXT-GENERATION SEQUENCING MARKET: RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 67
NEXT-GENERATION SEQUENCING MARKET: BREAKDOWN OF PRIMARIES
 
 
 
 
 
 
FIGURE 68
NEXT-GENERATION SEQUENCING MARKET: INSIGHTS FROM PRIMARIES
 
 
 
 
 
 
FIGURE 69
GLOBAL NEXT-GENERATION SEQUENCING MARKET ESTIMATION, 2025
 
 
 
 
 
 
FIGURE 70
NEXT-GENERATION SEQUENCING MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH), 2025
 
 
 
 
 
 
FIGURE 71
ILLUSTRATIVE EXAMPLE OF ILLUMINA, INC.: REVENUE ANALYSIS, 2025
 
 
 
 
 
 
FIGURE 72
SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 73
NEXT-GENERATION SEQUENCING MARKET: CAGR PROJECTIONS
 
 
 
 
 
 
FIGURE 74
NEXT-GENERATION SEQUENCING MARKET: DATA TRIANGULATION
 
 
 
 
 
 

Methodology

This study of the next-generation sequencing market relied on secondary sources, directories, and databases to gather pertinent information. To collect and validate key qualitative and quantitative data and to evaluate market growth prospects, in-depth interviews were conducted with numerous primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the next-generation sequencing market using several research strategies, the final market size was derived by triangulating data from primary research.

Secondary Research

Secondary sources for this research study include publications from government sources. These include the Centers for Disease Control and Prevention (CDC), the US Food and Drug Administration (FDA), the World Health Organization (WHO), the American Cancer Society (ACS), the National Center for Biotechnology Information (NCBI), the National Institutes of Health (NIH), the National Human Genome Research Institute (NHGRI), the International Agency for Research on Cancer (IARC), the National Institute for Infectious Diseases (IRCCS), the Association for Clinical Genomic Science (ACGS), the American Society of Human Genetics (ASHG), the European Society of Human Genetics (ESHG), the Asia Pacific Society of Human Genetics (APSHG), Nature Reviews Genetics, Nature Methods, the Biotechnology and Biological Sciences Research Council (BBSRC), the Organisation for Economic Co-operation and Development (OECD), Genome Research, the National Cancer Institute (NCI), the European Medicines Agency (EMA), the Population Health Research Institute (PHRI), PubMed, the World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data were collected and analyzed to determine the overall size of the global next-generation sequencing market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge of the global next-generation sequencing market through secondary research. Several primary interviews were conducted with market experts from the supply side, including C-level and D-level executives, operational managers, and marketing & sales managers at key manufacturers, distributors, and channel partners of companies providing NGS; and from the demand side, including personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries, CROs, and other end users. These interviews were conducted across six major regions, including North America, Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Next Generation Sequencing Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both, the top-down and bottom-up approaches were used to estimate and validate the total size of the next-generation sequencing market. These methods were also used extensively to estimate the size of various subsegments within the market. The research methodology for estimating market size includes the following.

Next Generation Sequencing Market Top Down and Bottom Up Approach

Data Triangulation

To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Next-generation sequencing (NGS) refers to non-Sanger-based, high-throughput DNA sequencing technologies. These technologies sequence DNA strands simultaneously, yielding substantially higher throughput and reducing the need for fragment-cloning methods often used in Sanger genome sequencing. NGS is fundamentally based on sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, and nanopore sequencing.

Key Stakeholders

  • NGS instrument manufacturers, vendors, and distributors
  • NGS service providers
  • NGS bioinformatics/data analysis companies
  • Research laboratories and academic institutes
  • Venture capitalists and other government funding organizations
  • Research and consulting firms
  • Healthcare institutions (hospitals and diagnostic clinics)
  • Pharmaceutical and biotechnology companies
  • Academic and government research institutes
  • Life science companies

Report Objectives

  • To define, describe, and forecast the next-generation sequencing market based on offering, product type, platform technology, product workflow, product end user, service type, service workflow, service end user, application, and region
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall next-generation sequencing market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
  • To profile key players in the global next-generation sequencing market and comprehensively analyze their platforms, reagents, kits, consumables, and service portfolios, market position, and core competencies
  • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the next-generation sequencing market
  • To benchmark players within the next-generation sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy.

Available customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the Rest of Europe next-generation sequencing market, by country
  • Further breakdown of the Rest of Asia Pacific next-generation sequencing market, by country
  • Further breakdown of the Rest of Latin America next-generation sequencing market, by country
  • Further breakdown of the Rest of Middle East next-generation sequencing market, by country

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Segment Analysis

  • Further breakdown of the other application and other end users area into subsegments
  • Cross-segment analysis.

 

Key Questions Addressed by the Report

What revenue strategies are market leaders using to dominate the Next-Generation Sequencing Industry by 2029?

Market leaders like Illumina and Roche are using bundled contracts that include reagents, software, and maintenance, turning instrument sales into long-term revenue streams. Thermo Fisher is expanding its reach through complete sequencing solutions using the Ion Torrent Genexus Dx platform. Companies are also forming partnerships, such as Illumina's collaboration with NVIDIA, to offer GPU-accelerated cloud analysis. By 2029, compact sequencers from Oxford Nanopore and Genapsys are expected to expand real-time and remote lab applications.

Which overlooked markets are emerging as high-ROI zones in the Next-Generation Sequencing Industry?

Latin America, Southeast Asia, and Africa are emerging as high-return markets. In Mexico, the OriGen project is sequencing over 10,000 genomes, making it attractive for local NGS investments. In March 2025, Illumina renewed its partnership with Africa CDC to equip national labs with NGS tools. In Southeast Asia, Gene Solutions partnered with Element Biosciences in April 2025 to bring cost-effective NIPT and oncology assays to Singapore and Vietnam.

How are fast-track approvals in North America driving early revenue for Next-Generation Sequencing players?

FDA fast-track programs have helped companies reduce approval times and generate revenue earlier. In October 2024, Thermo Fisher received FDA approval for the Oncomine Dx Target Test, quickly unlocking cartridge orders and contracts. Illumina’s TruSight Oncology panel was approved in August 2024 and also secured early Medicare coverage, helping the company capture initial sales sooner than expected.

What funding signal the next big shift in the Next-Generation Sequencing Market?

Recent investments are focusing on software, consumables, and hardware innovation. In May 2025, SeqOne Genomics raised USD 23.2 million to expand its AI-driven platform. In January 2025, Senseera secured USD 7.1 million for its liquid biopsy technology. In July 2024, Element Biosciences raised USD 277 million to support its high-throughput AVITI sequencer. These investments indicate a shift toward software development, non-invasive diagnostics, and next-generation instruments.

What key innovation gaps offer untapped revenue potential in the Next-Generation Sequencing Market?

The market still lacks standardized, cloud-based bioinformatics tools, which could generate strong subscription-based revenue. Fully automated, microfluidic sample-to-answer platforms are another gap that could drive premium consumables and service contracts. Long-read systems that lower sequencing costs are also in demand. Companies like Ultima Genomics and Standard Bio are working to address these areas.

How are go-to-market models evolving to win in Asia Pacific?

In the Asia Pacific region, companies are forming local partnerships to leverage regulatory and bioinformatics expertise. For instance, in March 2023, Qiagen collaborated with SOPHiA Genetics to combine reagents with analytics in India and Southeast Asia. Illumina introduced the NovaSeqX platform in Thailand in October 2022, reducing per-sample costs and encouraging adoption in cost-sensitive markets.

How are supply chain shifts affecting profitability in the Next-Generation Sequencing Market?

Regulatory actions and localization efforts are changing how companies manage their supply chains. In March 2025, China banned the import of Illumina sequencers, forcing the company to reduce costs by 100 million dollars and revise its earnings guidance. At the same time, companies like Thermo Fisher have localized production, with its May 2023 facility in Singapore reducing logistics costs and improving margins on consumables.

Which technologies are accelerating market access and scale in the Next-Generation Sequencing Market?

Sample-to-answer platforms are speeding up adoption by simplifying workflows. Thermo Fisher’s Genexus System completes sequencing and analysis in under 24 hours, helping smaller labs implement NGS. In May 2024, Illumina launched an AI-driven variant calling tool that reduced analysis time to two hours. BGI’s new hub in Singapore now serves over 5,000 institutes with scalable cloud computing resources.

What government programs are fueling growth in the Next-Generation Sequencing Market across Regions?

Several national programs are creating demand for NGS technologies. In India, the Genome India Project launched in January 2020 is sequencing 10,000 genomes and building lab infrastructure. China’s 2023 Clinical Sequencing Pilot Program allows early commercialization of various assays. The European Union’s GenAI4EU program, launched in May 2024 under Horizon Europe, is investing 818 million dollars in AI-driven bioinformatics through 2027.

How are competitors aligning products with buyer needs in Asia Pacific?

In Asia Pacific, companies are adapting to local needs by developing region-specific products. GeneLife, a Japanese company, partnered with Illumina to create direct-to-consumer kits and a wellness app focused on Asian genetic variants. In October 2022, Pacific Biosciences introduced the Revio and Onso platforms across the region, giving labs a range of affordable and scalable options tailored to varying budgets and throughput demands.

 

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Next-generation Sequencing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Next-generation Sequencing Market

avtar

Jackson

May, 2022

Which company and region dominates the Next generation Sequencing Market ?.

avtar

James

May, 2022

What is the most popular next-generation sequencing platform today in Next generation Sequencing Market ?.

avtar

Aiden

Jun, 2026

After reviewing the Next-Generation Sequencing Market report, I see strong consolidation around clinical diagnostics adoption and clearer differentiation emerging between high-throughput platforms and targeted sequencing solutions..

avtar

Luna

Jun, 2026

From an investment standpoint, the Next-Generation Sequencing Market trajectory suggests I should prioritize companies with scalable bioinformatics pipelines rather than pure sequencing hardware exposure..

avtar

Jaxon

Jun, 2026

I find the operational complexity highlighted in the Next-Generation Sequencing Market insights particularly relevant, especially the growing dependency on cloud-based data analysis to manage sequencing output at scale..

bottom banner
DMCA.com Protection Status
popup img